GE HealthCare Technologies Inc. disclosed the pricing of their earlier declared secondary offering of 13 million shares, which stands at $82.25 per share. It's essential to note that the company itself isn't selling any shares, thus they will not gain any proceeds from the sale. Several prominent corporations including Morgan Stanley, BofA Securities, Citigroup, Evercore ISI, Goldman Sachs & Co. LLC, and J.P. Morgan will act as the lead joint book-running managers for this share offering.